Hasil Pencarian - Weam Othman Elbezanti
- Menampilkan 1 - 6 hasil dari 6
-
1
Alprazolam Prompts HIV-1 Transcriptional Reactivation and Enhances CTL Response Through RUNX1 Inhibition and STAT5 Activation oleh Angel Lin, Angel Lin, Weam Othman Elbezanti, Weam Othman Elbezanti, Alexis Schirling, Alexis Schirling, Adel Ahmed, Rachel Van Duyne, Simon Cocklin, Zachary Klase, Zachary Klase
Diterbitkan 2021-07-01
Artikel -
2
KS18, a Mcl-1 inhibitor, improves the effectiveness of bortezomib and overcomes resistance in refractory multiple myeloma by triggering intrinsic apoptosis oleh Omar S. Al-Odat, Omar S. Al-Odat, Weam Othman Elbezanti, Weam Othman Elbezanti, Krishne Gowda, Sandeep K. Srivastava, Shantu G. Amin, Subash C. Jonnalagadda, Tulin Budak-Alpdogan, Manoj K. Pandey
Diterbitkan 2024-10-01
Artikel -
3
-
4
Development of a novel Bruton’s tyrosine kinase inhibitor that exerts anti-cancer activities potentiates response of chemotherapeutic agents in multiple myeloma stem cell-like cell... oleh Weam Othman Elbezanti, Weam Othman Elbezanti, Omar S. Al-Odat, Omar S. Al-Odat, Robert Chitren, Robert Chitren, Jaikee Kumar Singh, Sandeep Kumar Srivastava, Krishne Gowda, Shantu Amin, Gavin P. Robertson, Venkatesh V. Nemmara, Subash C. Jonnalagadda, Tulin Budak-Alpdogan, Manoj K. Pandey
Diterbitkan 2022-09-01
Artikel -
5
Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells oleh Kuntal Bhowmick, Max von Suskil, Omar S. Al-Odat, Weam Othman Elbezanti, Subash C. Jonnalagadda, Tulin Budak-Alpdogan, Manoj K. Pandey
Diterbitkan 2024-06-01
Artikel -
6
Bruton’s Tyrosine Kinase Targeting in Multiple Myeloma oleh Max Von Suskil, Kazi Nasrin Sultana, Weam Othman Elbezanti, Omar S. Al-Odat, Robert Chitren, Amit K. Tiwari, Kishore B. Challagundla, Sandeep Kumar Srivastava, Subash C. Jonnalagadda, Tulin Budak-Alpdogan, Manoj K. Pandey
Diterbitkan 2021-05-01
Artikel